Clinical Trials Directory

Trials / Unknown

UnknownNCT03222661

Direct Comparison of SVOne Obtained Refraction to Subjective Manifest Refraction

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Smart Vision Labs · Industry
Sex
All
Age
12 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to compare the final glasses prescription based on refraction obtained with SVOne device to the final prescription obtained via subjective manifest refraction.

Detailed description

Uncorrected refractive error is the leading cause of vision impairment and the second leading cause of blindness worldwide, affecting 1 in 90 individuals (1). In the US population approximately 14 million individuals aged 12 years or older have visual impairment (defined as distance visual acuity of 20/50 or worse), of which more than 11 million individuals (2) could have their vision improved to 20/40 or better with refractive correction. Uncorrected refractive error impacts all aspects of life, including, but not limited to, loss of employment opportunities, inability to care for family, and inability to receive an education. SVOne is smartphone-based autorefractor, powered by wavefront aberrometry, due to its portability and accuracy it presents as an effective and accessible method of detecting refractive error and dispensing spectacles for better vision (3). In this study, for each patient, a single clinician will determine final prescription through manifest refraction, while a different clinician will determine final prescription using SVOne exam protocol. Sphere, cylinder and axis will be converted to power vectors and compared by linear regression analysis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTRefractionRefractive error measurement

Timeline

Start date
2017-09-01
Primary completion
2017-11-01
Completion
2017-11-01
First posted
2017-07-19
Last updated
2017-07-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03222661. Inclusion in this directory is not an endorsement.